Intratumoral heterogeneity and drug resistance in cancer
Abstract Intratumoral heterogeneity is the main cause of tumor treatment failure, varying across disease sites (spatial heterogeneity) and polyclonal properties of tumors that evolve over time (temporal heterogeneity). As our understanding of intratumoral heterogeneity, the formation of which is mai...
Saved in:
| Main Authors: | Yue-Chun Fu, Shao-Bo Liang, Min Luo, Xue-Ping Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Cancer Cell International |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12935-025-03734-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Extrachromosomal DNA as a carrier of extra copies of oncogenes for heterogeneity and malignancy of glioma
by: Lin-jian Wang, et al.
Published: (2025-05-01) -
Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2‐Mediated Transcriptional Network in Multiple Myeloma
by: Binzhen Chen, et al.
Published: (2025-06-01) -
Extrachromosomal circular DNA as a novel biomarker for the progression of colorectal cancer
by: Quanpeng Qiu, et al.
Published: (2025-04-01) -
Plasma cell-free extrachromosomal circular DNA is a molecular hallmark of preeclampsia
by: Peng Han, et al.
Published: (2025-01-01) -
Initial Screening of Extrachromosomal Circular DNA Candidates for Pork Meat Quality Traits Using Circle-Seq and RNA-Seq Analysis
by: Liyao Bai, et al.
Published: (2025-05-01)